Enovis ENOV Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Net Sales by Business | ||||||
| Prevention & Recovery | $272.02M— | —— | —— | —— | $272.58M— | |
| Reconstructive | $317.13M+8.3% | $292.88M+13.5% | $257.97M-5.8% | $273.98M-4.3% | $286.25M+4.5% | |
| Adjusted EBITDA (non-GAAP) by Business | ||||||
| Prevention & Recovery | $31.11M— | —— | —— | —— | $30.9M— | |
| Reconstructive | $72.46M+5.4% | $68.75M+31.0% | $52.47M+4.1% | $50.42M-26.2% | $68.3M+4.9% | |
| Total Assets by Business | ||||||
| Prevention & Recovery | $1.45B-1.6% | $1.47B— | —— | —— | —— | |
| Reconstructive | $2.38B+0.9% | $2.36B-11.4% | $2.66B-13.4% | $3.08B+3.4% | $2.98B+7.7% | |
| Other Cost and Expense, Operating by Business | ||||||
| Prevention & Recovery | $112.47M— | —— | —— | —— | $107.84M— | |
| Reconstructive | $149.28M+13.8% | $131.14M+2.2% | $128.26M-4.8% | $134.74M-2.6% | $138.4M+8.0% | |
| Operating Costs and Expenses by Business | ||||||
| Prevention & Recovery | $245.97M— | —— | —— | —— | $245.85M— | |
| Reconstructive | $270.4M+8.8% | $248.48M+7.5% | $231.22M-6.6% | $247.51M-2.9% | $254.97M+9.2% | |
| Segment, Expenditure, Addition to Long-Lived Assets by Business | ||||||
| Prevention & Recovery | $7.2M— | —— | —— | —— | $8.79M— | |
| Reconstructive | $45.6M— | —— | $46.63M+20.1% | $38.83M+12.6% | $34.47M— | |
| Cost of Goods and Services Sold by Business | ||||||
| Prevention & Recovery | $125.76M— | —— | —— | —— | $128.76M— | |
| Reconstructive | $97.34M+3.0% | $94.49M+14.0% | $82.86M-9.7% | $91.75M-5.7% | $97.28M+8.1% | |
| Depreciation by Business | ||||||
| Prevention & Recovery | $5.07M— | —— | —— | —— | $4.17M— | |
| Reconstructive | $25.73M-96.7% | $771.01M+2,899% | $25.71M+7.3% | $23.96M-3.7% | $24.87M-94.2% | |
| Research and development expense by Business | ||||||
| Prevention & Recovery | $7.75M— | —— | —— | —— | $9.24M— | |
| Reconstructive | $23.79M+4.1% | $22.85M+13.7% | $20.1M-4.4% | $21.03M+9.0% | $19.29M+25.9% | |
| Provisions by Business | ||||||
| Prevention & Recovery | $1.4M— | —— | —— | —— | —— | |
| Reconstructive | $1.3M-77.6% | $5.8M+100% | $2.9M+867% | $300K-70.0% | $1M-93.0% | |
| Net Sales by Product | ||||||
| Bracing and Support | $114.88M-6.8% | $123.32M-2.9% | $126.98M+5.1% | $120.85M+5.0% | $115.09M-7.3% | |
| Other Prevention and Recovery | $55.86M-11.0% | $62.78M-12.1% | $71.41M+0.8% | $70.82M+6.3% | $66.62M-5.2% | |
| Surgical | $317.13M+8.3% | $292.88M+13.5% | $257.97M-5.8% | $273.98M-4.3% | $286.25M+4.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Enovis break its business down?
- Enovis (ENOV) reports net sales by business across 2 parts — Prevention & Recovery and Reconstructive. Each is extracted from the segment footnotes and tracked over time.
- Where does Enovis's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Enovis's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
